ReShape Lifesciences's market cap is currently $788.38K. The company's EPS TTM is $-16.396; its P/E ratio is ―; ReShape Lifesciences is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 8.68M	$ 11.24M	$ 13.60M	$ 11.30M	$ 15.09M
Gross Profit	$ 5.55M	$ 6.80M	$ 8.35M	$ 6.26M	$ 9.30M
Operating Income	$ -14.64M	$ -27.08M	$ -27.75M	$ -12.46M	$ -15.89M
EBITDA	$ -14.48M	$ -24.93M	$ -60.62M	$ -18.09M	$ -17.22M
Net Income	$ -11.39M	$ -46.21M	$ -61.93M	$ -21.63M	$ -74.21M
Balance Sheet
Cash & Short-Term Investments	$ 4.46M	$ 3.85M	$ 22.77M	$ 2.96M	$ 2.94M
Total Assets	$ 10.66M	$ 11.14M	$ 54.26M	$ 37.06M	$ 39.66M
Total Debt	$ 262.00K	$ 171.00K	$ 279.00K	$ 477.00K	$ 768.00K
Net Debt	$ -4.20M	$ -3.68M	$ -22.49M	$ -2.48M	$ -2.17M
Total Liabilities	$ 4.00M	$ 7.48M	$ 8.19M	$ 22.57M	$ 15.55M
Stockholders' Equity	$ 6.66M	$ 3.66M	$ 46.07M	$ 14.49M	$ 24.11M
Cash Flow
Free Cash Flow	$ -17.00M	$ -22.03M	$ -15.73M	$ -8.94M	$ -14.21M
Operating Cash Flow	$ -16.96M	$ -21.90M	$ -15.38M	$ -8.55M	$ -14.20M
Investing Cash Flow	$ -10.00K	$ -92.00K	$ 1.85M	$ -2.39M	$ -2.01M
Financing Cash Flow	$ 17.57M	$ 3.13M	$ 33.30M	$ 11.07M	$ 13.66M

Currency in USD

ReShape Lifesciences Earnings and Revenue History

Income Statement >

ReShape Lifesciences Debt to Assets

Balance Sheet >

ReShape Lifesciences Cash Flow

Cash Flow >

ReShape Lifesciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing